The interdisciplinary fracture liaison service improves health-related outcomes and survival of older adults after hip fracture surgical repair

• Published in: Archives of osteoporosis Vol. 17; no. 1; p. 135
• Main Authors: Ruggiero, Carmelinda, Baroni, Marta, Talesa, Giuseppe Rocco, Cirimbilli, Alessandro, Prenni, Valentina, Bubba, Valentina, Parretti, Luca, Bogini, Riccardo, Duranti, Giuliana, Caraffa, Auro, Boccardi, Virginia, Mecocci, Patrizia, Rinonapoli, Giuseppe
• Format: Journal Article
• Language: English
• Published: London Springer London 01.12.2022
• Subjects: Aged; Bone Density Conservation Agents - therapeutic use; Calcium - therapeutic use; Endocrinology; Hip Fractures - complications; Humans; Medicine; Medicine & Public Health; Original; Original Article; Orthopedics; Osteoporosis - epidemiology; Osteoporotic Fractures - epidemiology; Osteoporotic Fractures - surgery; Secondary Prevention; Vitamin D - therapeutic use; Osteoporosis; Hip fracture; Fracture liaison service; Anti-osteoporosis treatments; Fragility fractures
• ISSN: 1862-3522; 1862-3514
• DOI: 10.1007/s11657-022-01171-0

Summary Due to the high burden of fragility fractures, we developed an interdisciplinary FLS care pathway for early management and monitoring of older adults discharged from a high-volume trauma center after hip fracture repair. Interdisciplinary FLS effectively improves up to 1-year adherence to treatments for secondary prevention of fragility fractures, reduces health facility admission, and improves long-term survival. Purpose To compare adherence to secondary fragility fracture prevention, falls, healthcare facility admissions, and mortality between hip fracture older adults who entered the fracture liaison services pathway of care (FLS-CP) and those managed according to the usual traumatologist model of care (U-CP). Methods Prospective observational study enrolling subjects aged ≥ 65 years discharged by high-volume trauma center after hip fracture repair from February 2016 to February 2017, who consecutively entered FLS-CP or U-CP according to their preference and goals. Results Compared to U-CP, those in FLS-CP had higher initiation rate and up to 1-year adherence to secondary prevention of fragility fracture, including vitamin D and calcium (87.7% vs 36.9%; p  < 0.0001), specific anti-osteoporosis drugs (75.1% vs 8.0%; p  < 0.0001), and complete anti-fracture therapy (72.3% vs 5.7%; p  < 0.0001). Older adults belonging to FLS-CP showed a lower likelihood of healthcare facility admission (RR 0.597; 95% CI 0.398–0.895; p  = 0.0125), with a longer re-hospitalization-free survival (176.4 vs 88.7 days; p  = 0.0152) than those in U-CP. One-year incidence of falls and fractures was similar between groups, with a lower tendency of the subjects in the FLS-CP to be multiple fallers (19% vs 34.8%; OR 0.057; 95% CI 0.004–0.876; p  = 0.0690). The FLS-CP group experienced a lower 1-year (87.2% vs 74.3%; p  = 0.001) and 3-year mortality (67.9% vs 55.6%; p  = 0.0245) and a lower adjusted 5-year mortality hazard ratio (50.2% vs 58%; HR = 0.76; 95% CI 0.60; 0.96). Conclusion The FLS-CP may improve initiation and adherence to secondary prevention of fragility fractures, reduces healthcare facility admission, and improves long-term survival.